Stay updated on CYAD-211 Safety, Activity & Kinetics in Myeloma Clinical Trial
Sign up to get notified when there's something new on the CYAD-211 Safety, Activity & Kinetics in Myeloma Clinical Trial page.

Latest updates to the CYAD-211 Safety, Activity & Kinetics in Myeloma Clinical Trial page
- Check5 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the record history, and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed from the footer.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe history shows addition of Revision: v3.3.2 and removal of Revision: v3.2.0, reflecting internal page versioning. These changes do not affect trial data or public content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page no longer displays the government funding status notice across ClinicalTrials.gov; no changes to the study data, status, or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check55 days agoChange DetectedVersion 2 updated the recruitment status of the study. Version 3 updated the recruitment status, study design, eligibility criteria, and locations/contacts.SummaryDifference0.1%

- Check84 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference13%

- Check91 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.3%

Stay in the know with updates to CYAD-211 Safety, Activity & Kinetics in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CYAD-211 Safety, Activity & Kinetics in Myeloma Clinical Trial page.